Old Web
English
Sign In
Acemap
>
authorDetail
>
Abdallah T.M. Shbair
Abdallah T.M. Shbair
Bezmialem Foundation University
Medicine
Internal medicine
Oncology
Proportional hazards model
Bevacizumab
5
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Relationship with programmed cell death ligand 1 (PD-L1) and DTI features in brain metastases of non-small cell lung cancer; Preliminary study.
2021
Temel Fatih Yilmaz
Ismail Yurtsever
Haci Mehmet Türk
Mehmet Ali Gultekin
Mehmet Besiroglu
Dilek Hacer Cesme
Abdallah T.M. Shbair
Alpay Alkan
Show All
Source
Cite
Save
Citations (0)
A case report of fulminant hepatitis due to ribociclib with confirmed by liver biopsy in breast cancer
2021
Journal of Oncology Pharmacy Practice
Atakan Topcu
Ayse Irem Yasin
Abdallah T.M. Shbair
Mehmet Besiroglu
Melih Simsek
Zehra Sucuoglu
Ismail Yurtsever
Zuhal Gucin
Mesut Seker
Haci Mehmet Türk
Show All
Source
Cite
Save
Citations (0)
Systemic Inflammatory Markers for Prediction of Bevacizumab Benefit in Glioblastoma Multiforme.
2021
Jcpsp-journal of The College of Physicians and Surgeons Pakistan
Mehmet Besiroglu
Abdallah T.M. Shbair
Ayse Irem Yasin
Atakan Topcu
Haci Mehmet Türk
Tarık Demir
Show All
Source
Cite
Save
Citations (0)
Anxiety levels of breast cancer patients in Turkey during the COVID-19 pandemic.
2021
Future Oncology
Ayse Irem Yasin
Atakan Topcu
Abdallah T.M. Shbair
Zehra Sucuoglu Isleyen
Ahmet Öztürk
Mehmet Besiroglu
Haci Mehmet Türk
Show All
Source
Cite
Save
Citations (0)
Is the Duration of Temozolomide Predictive for Sequential Bevacizumab Treatment Responses in the Glioblastoma Multiforme Cancer Setting
2021
Jcpsp-journal of The College of Physicians and Surgeons Pakistan
Mehmet Besiroglu
Tarık Demir
Abdallah T.M. Shbair
Ayse Irem Yasin
Atakan Topcu
Haci Mehmet Türk
Show All
Source
Cite
Save
Citations (0)
1